Monensin Dosage Optimization for Dairy Feed Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The specific effects of monensin doses on lactating cows, particularly regarding milk components and milk yield, are unknown, and existing formulations do not effectively optimize milk production efficiency and fatty acid profiles in ruminants.

Innovation Solution

The use of dietary formulations containing specific amounts of monensin, ranging from 11 g/ton to 14.5 g/ton, in ruminant feeds to enhance milk production efficiency, milk fat yield, milk protein yield, and fatty acid profiles without negatively impacting milk fat percentages.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If monensin is included in ruminant feed at broad ranges (11 g/ton to 22 g/ton), then feed efficiency may be improved, but the specific effects on milk components and milk yield are unknown and may have adverse impacts

Engineering Contradiction:
Improvefeed efficiencyVSAvoidmilk component stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by identifying and implementing an optimal monensin dosage range (11-14.5 g/ton) that transforms the uncertain broad-range effects into predictable, reliable outcomes for milk production efficiency and fatty acid profiles while maintaining milk fat percentages

Inventive Principle:
Principle #35Parameter changes

2Productivity

If higher doses of monensin are fed to lactating cows, then milk production efficiency may increase, but milk fat percentages could be negatively impacted

Engineering Contradiction:
Improvemilk production efficiencyVSAvoidmilk fat percentage
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent resolves this contradiction by changing the dosage parameter to an optimal range (11-14.5 g/ton) that simultaneously improves milk production efficiency (ECM/DMI) and maintains favorable milk fat percentages, eliminating the need to choose between these conflicting outcomes

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If specific monensin doses are used, then fatty acid profile and energy corrected milk are improved, but the optimal dose range is currently unknown

Engineering Contradiction:
Improvefatty acid profile qualityVSAvoidoptimal dosage knowledge
Core Design Contradiction:
Manufacturing precisionVSLoss of information

Solution Approach 1:

The patent applies feedback by establishing evidence-based dosage guidelines (11-14.5 g/ton) that provide actionable information to practitioners, allowing them to achieve predictable improvements in fatty acid profiles and energy corrected milk production efficiency without guessing or using broad-range dosing

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20230255927A1Monensin levels for modern dairy diet
Publication Date: 2023.08.17 ELANCO TIERGESUNDHEIT AG
  • US20230255927A1 patent drawing
  • US20230255927A1 patent drawing
  • US20230255927A1 patent drawing

AI summary

The present disclosure provides formulations and methods for administration of dietary monensin to be fed to ruminants, including cattle. As described herein, monensin can provide beneficial effects of increasing dietary monensin concentration on milk yield and milk component yield, including milk fat yield, milk fat percentage, milk protein yield, and milk protein percentage.